Skip to main content

Table 5 Significant correlations in percentage changes between anthropometric measurements (body fat percentage, weight, BMI, waist, hip, wrist and neck circumferences, waist-hip ratio) with lipid values in cyclosporine A and tacrolimus groups throughout the study

From: The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients

Lipid parameters

CsA group

Tac group

Total-cholesterol

Mo 6: WrC (r: 0.272, p = 0.037)

Mo 12: WaC (r: 0.267, p = 0.030), HC (r: 0.339, p = 0.005)

Mo 36: WaC (r: 0.339, p = 0.011)

HDL-cholesterol

Mo 1: W (r: 0.330, p = 0.011), BMI (r: 0.331, p = 0.011)

-

Mo 3: W (r: 0.274, p = 0.040), BMI (r: 0.274, p = 0.040), WrC (r: 0.277, p = 0.037)

Mo 24: WaC (r: -0.272, p = 0.035)

Mo 36: WHR (r: -0.287, p = 0.032)

Mo 48: WrC (r: -0.291, p = 0.035)

Triglyceride

Mo 6: W (r: 0.319, p = 0.014), BMI (r: 0.319, p = 0.014), BF% (r: 0.411, p = 0.001)

Mo 12: W (r: 0.369, p = 0.002), BMI (r: 0.369, p = 0.002), WaC (r: 0.246, p = 0.047), HC (r: 0.316, p = 0.010), BF% (r: 0.265, p = 0.032)

Mo 24: WHR (r: 0.270, p = 0.037), WrC (r: 0.327, p = 0.011), NC (r: 0.308, p = 0.017)

Mo 36: BF% (r: 0.269, p = 0.047)

Mo 36: NC (r: 0.326, p = 0.014)

Mo 48: NC (r: 0.277, p = 0.043)

LDL-cholesterol

Mo 6: WrC (r: 0.262, p = 0.045), NC (r: 0.308, p = 0.018)

Mo 1: BF% (r: -0.261, p = 0.034)

Mo 36: WaC (r: 0.276, p = 0.039), NC (r: 0.398, p = 0.002)

  1. CsA cyclosporine A, Tac tacrolimus, W weight, BMI body mass index, WaC waist circumference, HC hip circumference, WHR waist-to-hip ratio, WrC wrist circumference, NC neck circumference